Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| argenx SEADR(ARGX) | 92,500 | 92,500 | 0 | $50.14M | $56.89M | 28.95% | +$6.75M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 663,381 | 727,982 | +64,601 | $34.75M | $40.75M | 20.74% | +$6.00M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,504,307 | 2,274,157 | +769,850 | $27.20M | $18.47M | 9.40% | -$8.73M |
| Axsome Therapeutics, Inc.(AXSM) | 209,632 | 174,769 | -34,863 | $18.84M | $14.79M | 7.53% | -$4.05M |
| Disc Medicine, Inc.(IRON) | 25,543 | 185,000 | +159,457 | $1.26M | $11.73M | 5.97% | +$10.47M |
| Avadel Pharmaceuticals Plc | 1,100,000 | 1,004,790 | -95,210 | $14.43M | $10.56M | 5.37% | -$3.87M |
| Revolution Medicines, Inc.(RVMD) | 0 | 210,000 | +210,000 | $0 | $9.19M | 4.67% | +$9.19M |
| Pliant Therapeutics, Inc.(PLRX) | 380,000 | 535,494 | +155,494 | $4.26M | $7.05M | 3.59% | +$2.79M |
| TScan Therapeutics, Inc.(TCRX) | 825,341 | 1,755,987 | +930,646 | $4.11M | $5.34M | 2.72% | +$1.23M |
| Cidara Therapeutics Inc | 182,426 | 196,949 | +14,523 | $1.96M | $5.11M | 2.60% | +$3.15M |
| Trevi Therapeutics, Inc.(TRVI) | 250,000 | 1,084,135 | +834,135 | $835.0K | $4.47M | 2.27% | +$3.63M |
| Stoke Therapeutics, Inc.(STOK) | 157,514 | 305,387 | +147,873 | $1.94M | $3.37M | 1.71% | +$1.43M |
| Soleno Therapeutics Inc | 57,983 | 70,027 | +12,044 | $2.93M | $3.15M | 1.60% | +$220.2K |
| Kymera Therapeutics, Inc.(KYMR) | 0 | 77,535 | +77,535 | $0 | $3.12M | 1.59% | +$3.12M |
| Atyr Pharma Inc | 1,736,477 | 432,561 | -1,303,916 | $3.06M | $1.57M | 0.80% | -$1.49M |
| Cytokinetics, Incorporated(CYTK) | 466,813 | 20,000 | -446,813 | $24.65M | $940.8K | 0.48% | -$23.71M |
| Allakos Inc | 649,957 | 0 | -649,957 | $424.6K | $0 | — | -$424.6K |
| Protagonist Therapeutics Inc | 240,000 | 0 | -240,000 | $10.80M | $0 | — | -$10.80M |